Why are we doing this study?
Available medical research suggests that escitalopram (Lexapro) is often effective for Body Dysmorphic Disorder (BDD). It is currently considered a first-choice treatment for BDD.
In this study, we are assessing how people who initially improve after 14 weeks of treatment with Lexapro do when Lexapro is either discontinued or continued for another 6 months. This is a very important question that patients and doctors often ask and which this study will help to answer.
What is Escitalopram?
Escitalopram (Lexapro) is a marketed medication that's used to treat depression and other disorders. Lexapro also often helps decrease obsessive thoughts and compulsive behaviors, anxiety, and social anxiety. Lexapro and other similar medications have been shown to be effective for a majority of people who have Body Dysmorphic Disorder.
What will it entail for me?
The study consists of 2 phases:
Phase 1: After an initial evaluation, you will receive Lexapro for 14 weeks. Each study visit will take about 45 minutes a week for the first month and about 45 minutes every other week for the rest of the 14 weeks.
Phase 2: If you improve sufficiently in Phase